New Key Statistics Module, Z-Score and F-Score
SHSE:600216 Key Ratios
Market Cap ¥ M | 18,021.09 |
Enterprise Value ¥ M | 16,806.91 |
P/E(ttm) | 18.37 |
PE Ratio without NRI | 21.10 |
Forward PE Ratio | 17.81 |
Price/Book | 1.74 |
Price/Sales | 1.95 |
Price/Free Cash Flow | 62.12 |
Price/Owner Earnings | 90.12 |
Payout Ratio % | 0.17 |
Revenue (TTM) ¥ M | 9,030.00 |
EPS (TTM) ¥ | 1.02 |
Beneish M-Score | -2.39 |
10-y EBITDA Growth Rate % | 9.90 |
5-y EBITDA Growth Rate % | 6.40 |
y-y EBITDA Growth Rate % | 258.50 |
EV-to-EBIT | 15.54 |
EV-to-EBITDA | 15.54 |
PEG | 3.30 |
Shares Outstanding M | 961.64 |
Net Margin (%) | 10.83 |
Operating Margin % | 10.18 |
Pre-tax Margin (%) | 11.36 |
Quick Ratio | 1.78 |
Current Ratio | 2.61 |
ROA % (ttm) | 7.57 |
ROE % (ttm) | 9.94 |
ROIC % (ttm) | 8.28 |
Dividend Yield % | 0.82 |
Altman Z-Score | 5.58 |
SHSE:600216 Number of Guru Trades
SHSE:600216 Volume of Guru Trades
Gurus Latest Trades with SHSE:600216
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600216 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Medicine Co Ltd Insider Transactions
No Available Data